Formulation and nebujization of fluticasone propiondte-loaded crossmark lipid nanocarriers
ln I1J:ed nu tic.lsone pro lon,lte ( r) is fi ('<1 prcscnlJe 15 a fi r sr -llIle therapy for lhe enec live ma ndgemenl of pulmonary dls~dses such as "sthma. As nanocarriers offe mJny ddvdntdges over otl1er drug delivery systems. this stuoy investig [...]
UMERSKA CELIA [1], MOUZOUVI ROSMONDE [2], BIGOT KOFFI ANDRÉ [3], SAULNIER PATRICK [4],